The DOI matches its Crossref record; 164 of the 164 references it cites were found in a registry or an index.
Platelet chemokines and chemokine receptors, linking hemostasis, inflammation, and host defense
Abstract
Blood platelets play critical roles in hemostasis, providing rapid essential protection against bleeding and catalyzing the important slower formation of stable blood clots via the coagulation cascade. They are also involved in protection from infection by phagocytosis of pathogens and by secreting chemokines that attract leukocytes. Platelet function usually is activated by primary agonists such as adenosine diphosphate (ADP), thrombin, and collagen, whereas secondary agonists like adrenalin do not induce aggregation on their own but become highly effective in the presence of low levels of primary agonists. Current research has revealed that chemokines represent an important additional class of agonists capable of causing significant activation of platelet function. Early work on platelet alpha-granule proteins suggested that platelet factor 4, now known as CXCL4, modulated aggregation and secretion induced by low agonist levels. Subsequent reports revealed the presence in platelets of messenger RNA for several additional chemokines and chemokine receptors. Three chemokines in particular, CXCL12 (SDF-1), CCL17 (TARC), and CCL22 (MDC), recently have been shown to be strong and rapid activators of platelet aggregation and adhesion after their binding to platelet CXCR4 or CCR4, when acting in combination with low levels of primary agonists. CXCL12 can be secreted by endothelial cells and is present in atherosclerotic plaques, whereas CCL17 and CCL22 are secreted by monocytes and macrophages. Platelet activation leads to the release of alpha-granule chemokines, including CCL3 (MIP-1alpha), CCL5 (RANTES), CCL7 (MCP-3), CCL17, CXCL1 (growth-regulated oncogene-alpha), CXCL5 (ENA-78), and CXCL8 (IL-8), which attract leukocytes and further activate other platelets. These findings help to provide a direct linkage between hemostasis, infection, and inflammation and the development of atherosclerosis.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Consequent to vascular damage, activated platelets can also release an array of cellular growth factors and angiogenic factors such as PDGF and VEGF, as well as inflammatory mediators such as IL-8 [79,80,81].”
From The Pathogenesis of Adenomyosis vis-à-vis Endometriosis (2020) · cites this paper as [80]
Citations
Cites
Atherosclerosis--an inflammatory disease
Ross, R. (1999) · New England Journal of Medicine · doi:10.1056/nejm199901143400207 · Cited by 21,725
Zlotnik, A., & Yoshie, O. (2000) · Immunity · doi:10.1016/s1074-7613(00)80165-x · Cited by 3,923
Thrombin signalling and protease-activated receptors
Coughlin, S. R. (2000) · Nature · doi:10.1038/35025229 · Cited by 2,495
CD40 ligand on activated platelets triggers an inflammatory reaction of endothelial cells
Henn, V., Slupsky, J. R., Gräfe, M., Anagnostopoulos, I., Förster, R., MÜLLER‐BERGHAUS, G., & Kroczek, R. A. (1998) · Nature · doi:10.1038/35393 · Cited by 2,082
Bonecchi, R., Bianchi, G., Panina‐Bordignon, P., D’Ambrosio, D., Lang, R., Borsatti, A., Sozzani, S., Allavena, P., Gray, P. A., Mantovani, A., et al. (1998) · The Journal of Experimental Medicine · doi:10.1084/jem.187.1.129 · Cited by 2,016
Gerard, C., & Rollins, B. J. (2001) · Nature Immunology · doi:10.1038/84209 · Cited by 1,357
Sørensen, T. L., Tani, M., Jensen, J. S., Pierce, V., Lucchinetti, C. F., Folcik, V. A., Qin, S., Rottman, J., Sellebjerg, F. T., Strieter, R. M., et al. (1999) · Journal of Clinical Investigation · doi:10.1172/jci5150 · Cited by 994
Yoshimura, T., Matsushima, K., Tanaka, S., Robinson, E. A., Appella, E., Oppenheim, J. J., & Leonard, E. J. (1987) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.84.24.9233 · Cited by 984
Chemokine receptors and their role in inflammation and infectious diseases
Murdoch, C., & Finn, A. H. R. (2000) · Blood · doi:10.1182/blood.v95.10.3032 · Cited by 844
Peled, A., Kollet, Ó., Ponomaryov, T., Petit, I., Franitza, S., Grabovsky, V., Magid, M., Nagler, A., Lider, O., Alon, R., et al. (2000) · Blood · doi:10.1182/blood.v95.11.3289 · Cited by 764
Flagged first, then by citations
Research works printed but not linked: 4
- Cerletti C., 2002, Platelets in Thrombotic and Non‐Thrombotic Disorders: Patho‐physiology, Pharmacology and Therapeutics, 412431
- Dobroski DR, 1998, Thrombosis and Hemorrhage, 837
- Levine J., 1998, Thrombosis and Hemorrhage, 1065
- Peerschke EI, 1998, Thrombosis and Hemorrhage, 229
Cited by
Sorted by citations
Items 101–200 of 315
Lax, S., Rayes, J., Wichaiyo, S., Haining, E. J., Lowe, K. L., Grygielska, B., Laloo, R., Flodby, P., Borok, Z., Crandall, E. D., et al. (2017) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00023.2017 · Cited by 64
Mean Platelet Volume Seems To Be a Valuable Marker in Patients with Systemic Sclerosis
Soydinç, S., Türkbeyler, İ. H., Pehlivan, Y., Soylu, G., Goktepe, F., Bilici, M. F., Zengin, O., Kısacık, B., & Onat, A. M. (2013) · Inflammation · doi:10.1007/s10753-013-9716-x · Cited by 64
Platelet Toll-Like Receptor Expression: The Link Between “Danger” Ligands and Inflammation
Garraud, O., & Cognasse, F. (2010) · Inflammation & Allergy - Drug Targets · doi:10.2174/187152810793937991 · Cited by 62
Virani, S. S., Nambi, V., Hoogeveen, R. C., Wasserman, B. A., Coresh, J., Gonzalez, F., Chambless, L. E., Mosley, T. H., Boerwinkle, E., & Ballantyne, C. M. (2010) · European Heart Journal · doi:10.1093/eurheartj/ehq367 · Cited by 63
Shiga toxin binds to activated platelets
Ghosh, S., Polanowska‐Grabowska, R., Fujii, J., Obrig, T. G., & Gear, A. R. L. (2004) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7933.2004.00638.x · Cited by 63
Self-citationAltered profile of chemokines in fibromyalgia patients
García, J. J., Cidoncha, A., Bote, E., Hinchado, M. D., & Ortega, E. (2013) · Annals of Clinical Biochemistry International Journal of Laboratory Medicine · doi:10.1177/0004563213506413 · Cited by 62
Khaiboullina, S. F., Levis, S., Morzunov, S. P., Martynova, E. V., Алексеевич, А. В., Gusev, O., Jeor, S. C. S., Lombardi, V. C., & Rizvanov, A. A. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.00567 · Cited by 62
Do Aspirin and Other Antiplatelet Drugs Reduce the Mortality in Critically Ill Patients?
Lösche, W., Boettel, J., Kabisch, B., Winning, J., Claus, R. A., & Bauer, M. W. (2011) · Thrombosis · doi:10.1155/2012/720254 · Cited by 61
Hu, L., Wu, T. H., Wang, B., Wei, Y., Kong, Q., Ye, Y., Yin, H., & Li, J. (2018) · Scientific Reports · doi:10.1038/s41598-017-18616-z · Cited by 60
Wang, J., Zhang, W., Nardi, M. A., & Li, Z. (2010) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2010.04168.x · Cited by 60
Liu, Z., Wang, Z., Huang, C., Fu, Z., Liu, Y., Wei, Z., Liu, S., Ma, C., Shen, J., & Duan, D. D. (2018) · Acta Pharmacologica Sinica · doi:10.1038/aps.2018.36 · Cited by 61
Deeva, I. B., Mariani, S., Luca, C. D., Pacifico, V., Leoni, L., Raskovic, D., Хараева, З. Ф., Korkina, L. G., & Pastore, S. (2009) · Cytokine · doi:10.1016/j.cyto.2009.09.014 · Cited by 59
Enterohemorrhagic Escherichia coli Pathogenesis and the Host Response
Karpman, D., & Ståhl, A.-L. (2014) · Microbiology Spectrum · doi:10.1128/microbiolspec.ehec-0009-2013 · Cited by 65
Deficiency of PAR4 Attenuates Cerebral Ischemia/Reperfusion Injury in Mice
Mao, Y., Zhang, M., Tuma, R. F., & Kunapuli, S. P. (2010) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/jcbfm.2009.283 · Cited by 59
Wang, W., Wu, C., Gao, Y., Li, F., Yu, X., & Jin, H. (2021) · BMC Immunology · doi:10.1186/s12865-021-00454-4 · Cited by 58
Welsh, J. D., Muthard, R. W., Stalker, T. J., Taliaferro, J. P., Diamond, S. L., & Brass, L. F. (2016) · Blood · doi:10.1182/blood-2015-09-672188 · Cited by 58
Guessous, F., Marcinkiewicz, M., Polanowska‐Grabowska, R., Kongkhum, S., Heatherly, D. P., Obrig, T. G., & Gear, A. R. L. (2005) · Infection and Immunity · doi:10.1128/iai.73.12.8306-8316.2005 · Cited by 58
Self-citationMicroenvironmental Regulation of Chemokine (C-X-C-Motif) Receptor 4 in Ovarian Carcinoma
Barbolina, M. V., Kim, M., Liu, Y., Shepard, J. A., Belmadani, A. A., Miller, R. J., Shea, L. D., & Stack, M. S. (2010) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-09-0463 · Cited by 57
Ottoboni, T., Quart, B. D., Pawasauskas, J. E., Dasta, J. F., Pollak, R. A., & Viscusi, E. R. (2019) · Regional Anesthesia & Pain Medicine · doi:10.1136/rapm-2019-100714 · Cited by 57
Emerging roles of platelets in cancer biology and their potential as therapeutic targets
Wang, L., Wang, X., Guo, E., Mao, X., & Miao, S. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.939089 · Cited by 55
Platelets as versatile regulators of cutaneous inflammation
Katoh, N. (2008) · Journal of Dermatological Science · doi:10.1016/j.jdermsci.2008.08.019 · Cited by 55
Role of chemokine receptors CXCR4 and CXCR7 for platelet function
Chatterjee, M., Rath, D., & Gawaz, M. (2015) · Biochemical Society Transactions · doi:10.1042/bst20150113 · Cited by 54
Thrombin activation and liver inflammation in advanced hepatitis C virus infection
González‐Reimers, E. (2016) · World Journal of Gastroenterology · doi:10.3748/wjg.v22.i18.4427 · Cited by 54
Panicot‐Dubois, L., Thomas, G. M., Furie, B. C., Furie, B., Lombardo, D., & Dubois, C. (2007) · Journal of Clinical Investigation · doi:10.1172/jci32655 · Cited by 49
Anti-inflammatory Renoprotective Effect of Clopidogrel and Irbesartan in Chronic Renal Injury
Tu, X., Chen, X., Xie, Y., Shi, S., Wang, J., Chen, Y., & Li, J. (2007) · Journal of the American Society of Nephrology · doi:10.1681/asn.2007020160 · Cited by 49
Mean Platelet Volume Is Elevated in Patients with Psoriasis Vulgaris
Kim, J. H., Lee, J., Kim, S. H., Kim, S. M., & Lee, M. (2015) · Yonsei Medical Journal · doi:10.3349/ymj.2015.56.3.712 · Cited by 48
Manne, B. K., Münzer, P., Badolia, R., Walker-Allgaier, B., Campbell, R. A., Middleton, E. A., Weyrich, A. S., Kunapuli, S. P., Borst, O., & Rondina, M. T. (2018) · Journal of Thrombosis and Haemostasis · doi:10.1111/jth.14005 · Cited by 48
Alessandri, A. L., Souza, A. L., Oliveira, S. C., Macedo, G. C., Teixeira, M. M., & Teixeira, A. L. (2006) · Inflammation Research · doi:10.1007/s00011-006-5136-9 · Cited by 48
Chemokines and thrombogenicity
Lambert, M. P., Sachais, B. S., & Kowalska, M. A. (2007) · Thrombosis and Haemostasis · doi:10.1160/th07-01-0046 · Cited by 48
Pharmacogenetics of adverse effects due to antiretroviral drugs.
Vidal, F., Gutiérrez, F., Gutiérrez, M. D. M., Olona, M., Sánchez, V., Mateo, G. M., Peraire, J., Viladés, C., Veloso, S., López-Dupla, M., et al. (2010) · PubMed · Cited by 47
Slow resolution of inflammation in severe adult dengue patients
Zhao, L., Huang, X., Hong, W., Qiu, S., Wang, J., Yu, L., Zeng, Y., Tan, X., & Zhang, F. (2016) · BMC Infectious Diseases · doi:10.1186/s12879-016-1596-x · Cited by 48
Differential-display PCR of peripheral blood for biomarker discovery in chronic fatigue syndrome
Steinau, M., Unger, E. R., Vernon, S. D., Jones, J. F., & Rajeevan, M. S. (2004) · Journal of Molecular Medicine · doi:10.1007/s00109-004-0586-4 · Cited by 47
CX 3 CR1 Deficiency Confers Protection From Intimal Hyperplasia After Arterial Injury
Liu, P., Patil, S. U., Rojas, M., Fong, A. M., Smyth, S. S., & Patel, D. D. (2006) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.0000234947.47788.8c · Cited by 47
Thromboinflammatory challenges in stroke pathophysiology
Szepanowski, F., Haupeltshofer, S., Vonhof, S. E., Frank, B., Kleinschnitz, C., & Casas, A. I. (2023) · Seminars in Immunopathology · doi:10.1007/s00281-023-00994-4 · Cited by 50
Harbi, S. A. A., Tamim, H., Al‐Dorzi, H. M., Sadat, M., & Arabi, Y. M. (2016) · BMC Pharmacology and Toxicology · doi:10.1186/s40360-016-0047-z · Cited by 46
Feng, X., Scheinberg, P., Samsel, L., Rios, O. J., Chen, J., McCoy, J. P., Ghanima, W., Bussel, J., & Young, N. S. (2012) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2012.04757.x · Cited by 44
Yan, D., Liu, X., Xu, H., & Guo, S. (2020) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgaa550 · Cited by 44
Olsnes, A. M., Motorin, D., Ryningen, A., Zaritskey, A. Y., & Bruserud, Ø. (2005) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-005-0080-z · Cited by 44
Coşkun, B. N., Öksüz, M., Ermurat, S., Tufan, A. N., Oruçoğlu, N., Doğan, A., Dalkılıç, E., & Pehlivan, Y. (2014) · European Journal of Rheumatology · doi:10.5152/eurjrheumatol.2014.034 · Cited by 43
Plummer, C., & Douglas, C. W. I. (2006) · FEMS Immunology & Medical Microbiology · doi:10.1111/j.1574-695x.2006.00161.x · Cited by 42
Platelets induce endothelial–mesenchymal transition and subsequent fibrogenesis in endometriosis
Yan, D., Liu, X., Xu, H., & Guo, S. (2020) · Reproductive BioMedicine Online · doi:10.1016/j.rbmo.2020.03.020 · Cited by 39
Chatterjee, M., Ehrenberg, A., Toska, L. M., Metz, L. M., Klier, M., Krüger, I., Reusswig, F., & Elvers, M. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21217906 · Cited by 40
The influence of low-grade inflammation on platelets in patients with stable coronary artery disease
Larsen, S. B., Grove, E. L., Würtz, M., Neergaard‐Petersen, S., Hvas, A., & Kristensen, S. D. (2015) · Thrombosis and Haemostasis · doi:10.1160/th14-12-1007 · Cited by 39
Thrombocytopenia in dengue infection: mechanisms and a potential application
Khazali, A. S., Hadrawi, W. H., Ibrahim, F., Othman, S., & Rashid, N. N. (2024) · Expert Reviews in Molecular Medicine · doi:10.1017/erm.2024.18 · Cited by 38
Dymicka-Piekarska, V., Matowicka-Karna, J., Gryko, M., Kemona-Chętnik, I., & Kemona, H. (2006) · Thrombosis Research · doi:10.1016/j.thromres.2006.11.002 · Cited by 38
Coleman, L. G., Polanowska‐Grabowska, R., Marcinkiewicz, M., & Gear, A. R. L. (2004) · Blood · doi:10.1182/blood-2003-08-2961 · Cited by 37
Self-citationYun, A. J., Lee, P. Y., & Bazar, K. A. (2004) · Medical Hypotheses · doi:10.1016/j.mehy.2004.08.023 · Cited by 36
Keating, A. K., Freehauf, C. L., Jiang, H., Brodsky, G. L., Stabler, S. P., Allen, R. H., Graham, D. K., Thomas, J. A., Hove, J. L. K. V., & Maclean, K. N. (2011) · Molecular Genetics and Metabolism · doi:10.1016/j.ymgme.2011.04.012 · Cited by 33
Key Chemokine Pathways in Atherosclerosis and Their Therapeutic Potential
Márquez, A. B., van der Vorst, E. P. C., & Maas, S. L. (2021) · Journal of Clinical Medicine · doi:10.3390/jcm10173825 · Cited by 37
Setzer, F., Oberle, V., Blaess, M. F., Möller, E., Rußwurm, S., Deigner, H., Claus, R. A., Bauer, M. W., Reinhart, K., & Lösche, W. (2006) · Platelets · doi:10.1080/09537100600760244 · Cited by 35
Extensive Characterization of Platelet Gel Releasate from Cord Blood in Regenerative Medicine
Parazzi, V., Lavazza, C., Boldrin, V., Montelatici, E., Pallotti, F., Marconi, M., & Lazzari, L. (2015) · Cell Transplantation · doi:10.3727/096368915x687471 · Cited by 34
Yu, C., Zhang, S., Wang, Y., Zhang, S., Luo, L., & Thorlacius, H. (2015) · Journal of Cellular Physiology · doi:10.1002/jcp.25081 · Cited by 35
Najafi, S., Asemani, Y., Majidpoor, J., Mahmoudi, R., Zarch, S. M. A., & Mortezaee, K. (2023) · Clinica Chimica Acta · doi:10.1016/j.cca.2023.117690 · Cited by 33
Dieckmann, L., Cole, S. W., & Kumsta, R. (2020) · Translational Psychiatry · doi:10.1038/s41398-020-0730-0 · Cited by 35
Prothrombotic Phenotype in COVID-19: Focus on Platelets
Barale, C., Melchionda, E., Morotti, A., & Russo, I. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms222413638 · Cited by 35
New frontiers for platelet CD154
Dewitte, A., Tanga, A., Villeneuve, J., Lepreux, S., Ouattara, A., Desmoulière, A., Combe, C., & Ripoche, J. (2015) · Experimental Hematology and Oncology · doi:10.1186/s40164-015-0001-6 · Cited by 36
Lapchak, P. H., Ioannou, A., Rani, P., Lieberman, L. A., Yoshiya, K., Kannan, L., Lucca, J. J. D., Kowalska, M. A., & Tsokos, G. C. (2012) · PLoS ONE · doi:10.1371/journal.pone.0039934 · Cited by 32
Chemokines in vascular pathology (Review)
Apostolakis, S. Z., Papadakis, E. C., Krambovitis, E., & Spandidos, D. A. (2006) · International Journal of Molecular Medicine · doi:10.3892/ijmm.17.5.691 · Cited by 32
Vps33b regulates Vwf‐positive vesicular trafficking in megakaryocytes
Dai, J., Lu, Y., Wang, C., Chen, X., Fan, X., Gu, H., Wu, X., Wang, K., Gartner, T. K., Zheng, J., et al. (2016) · The Journal of Pathology · doi:10.1002/path.4762 · Cited by 34
Mechanistic basis of heparin-induced thrombocytopenia
Poncz, M. (2005) · Seminars in Thoracic and Cardiovascular Surgery · doi:10.1053/j.semtcvs.2004.12.007 · Cited by 32
Cronin, B., Maus, T. M., Pretorius, V. G., Nguyen, L. C., Johnson, D., Ovando, J., Auger, W. R., Madani, M. M., Jamieson, S. W., Banks, D. A., et al. (2014) · Journal of Cardiothoracic and Vascular Anesthesia · doi:10.1053/j.jvca.2014.07.018 · Cited by 31
The role of human cytomegalovirus in atherosclerosis: a systematic review
Zhu, W., & Liu, S. (2020) · Acta Biochimica et Biophysica Sinica · doi:10.1093/abbs/gmaa005 · Cited by 31
Miyauchi, S., Maekawa, T., Yudai, A. O. K. I., Miyazawa, H., Tabeta, K., Nakajima, T. E., & Yamazaki, K. (2011) · Journal of Periodontal Research · doi:10.1111/j.1600-0765.2011.01441.x · Cited by 32
Role of Polymorphonuclear Leukocytes in the Pathophysiology of Typical Hemolytic Uremic Syndrome
Exeni, R. A., Fernández, G. C., & Palermo, M. S. (2007) · The Scientific World JOURNAL · doi:10.1100/tsw.2007.172 · Cited by 30
Tan, L. Y., Martini, C., Fridlender, Z. G., Bonder, C. S., Brown, M. P., & Ebert, L. M. (2017) · Clinical & Translational Immunology · doi:10.1038/cti.2017.7 · Cited by 30
Tamura, N., Kitajima, I., Kawamura, Y., Toda, E., Eguchi, Y., Ishida, H., & Goto, S. (2009) · Circulation Journal · doi:10.1253/circj.cj-08-0465 · Cited by 29
Heger, M., van Golen, R. F., Broekgaarden, M., van den Bos, R. R., Neumann, H. A. M., van Gulik, T. M., & van Gemert, M. J. C. (2013) · Lasers in Medical Science · doi:10.1007/s10103-013-1490-3 · Cited by 31
CXC chemokine ligand 4 (CXCL4) down-regulates CC chemokine receptor expression on human monocytes
Schwartzkopff, F., Petersen, F., Grimm, T. A., & Brandt, E. (2010) · Innate Immunity · doi:10.1177/1753425910388833 · Cited by 29
Ueba, T., Nomura, S., Inami, N., Yokoi, T., & Inoue, T. (2014) · Clinical and Applied Thrombosis/Hemostasis · doi:10.1177/1076029612467845 · Cited by 28
Platelet Count Is Associated with Plasma HIV Type 1 RNA and Disease Progression
Rieg, G. K., Yeaman, M. R., Lail, A. E., Donfield, S. M., Gomperts, E. D., Daar, E. S., & (HGDS), T. H. G. A. D. S. (2007) · AIDS Research and Human Retroviruses · doi:10.1089/aid.2006.0311 · Cited by 28
Picker, S. M., Steisel, A., & Gathof, B. S. (2009) · Transfusion Medicine and Hemotherapy · doi:10.1159/000203359 · Cited by 27
The heterodimerization of platelet-derived chemokines
Carlson, J., Baxter, S. A., Dréau, D., & Nesmelova, I. V. (2012) · Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics · doi:10.1016/j.bbapap.2012.09.010 · Cited by 27
Guessous, F., Polanowska‐Grabowska, R., Keepers, T. R., Obrig, T. G., Gear, A. R. L., & Marcinkiewicz, M. (2005) · Thrombosis and Haemostasis · doi:10.1160/th05-02-0115 · Cited by 27
Self-citationMiędzobrodzki, J., Panz, T., Plonka, P. M., Zajac, K., Dracz, J., Pytel, K. M., Mateuszuk, Ł., & Chłopicki, S. (2008) · Folia Histochemica et Cytobiologica · doi:10.2478/v10042-008-0052-1 · Cited by 27
Coll, B., Alonso‐Villaverde, C., Parra, S., Montero, M., Tous, M., Joven, J., & Masana, L. (2005) · AIDS · doi:10.1097/01.aids.0000183516.22266.dd · Cited by 27
Lee, P. Y., Yun, A. J., & Bazar, K. A. (2004) · Medical Hypotheses · doi:10.1016/j.mehy.2004.02.004 · Cited by 27
Bruserud, Ø. (2012) · Platelets · doi:10.3109/09537104.2012.678426 · Cited by 25
Parra‐Izquierdo, I., Melrose, A. R., Pang, J., Lakshmanan, H. H. S., Reitsma, S. E., Vavilapalli, S. H., Larson, M. K., Shatzel, J. J., McCarty, O. J. T., & Aslan, J. E. (2021) · Platelets · doi:10.1080/09537104.2021.1934665 · Cited by 27
Isoflurane prevents acute lung injury through ADP-mediated platelet inhibition
Harr, J. N., Moore, E. E., Stringham, J. R., Wohlauer, M. V., Fragoso, M., Jones, W. L., Gamboni, F., Silliman, C. C., & Banerjee, A. M. (2012) · Surgery · doi:10.1016/j.surg.2012.05.002 · Cited by 25
Fully Human Antagonistic Antibodies against CCR4 Potently Inhibit Cell Signaling and Chemotaxis
Hagemann, U. B., Gunnarsson, L., Géraudie, S., Scheffler, U., Griep, R. A., Reiersen, H., Duncan, A., & Kiprijanov, S. M. (2014) · PLoS ONE · doi:10.1371/journal.pone.0103776 · Cited by 25
Pelleri, M. C., Piovesan, A., Caracausi, M., Berardi, A. C., Vitale, L., & Strippoli, P. (2014) · BMC Medical Genomics · doi:10.1186/s12920-014-0063-z · Cited by 25
Amelirad, A., Shamsasenjan, K., Akbarzadehlaleh, P., & Sarvar, D. P. (2019) · Advanced Pharmaceutical Bulletin · doi:10.15171/apb.2019.005 · Cited by 25
Yang, Z. H., Zhang, Z., Wen, J., Wang, X., Lü, B., Yang, Z., Zhang, W., Wang, M., Feng, X., Ling, C., et al. (2010) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2009-2194 · Cited by 25
Shelburne, C. E., Coopamah, M. D., Sweier, D. G., An, F. Y., & Lopatin, D. E. (2007) · Cellular Microbiology · doi:10.1111/j.1462-5822.2007.00897.x · Cited by 25
Effects and Side Effects of Platelet Transfusion
Cognasse, F., Hally, K. E., Fauteux‐Daniel, S., Eyraud, M., Arthaud, C., Fagan, J., Mismetti, P., Hamzeh‐Cognasse, H., Laradi, S., Garraud, O., et al. (2021) · Hämostaseologie · doi:10.1055/a-1347-6551 · Cited by 24
Li, B., Wang, R., Wang, S., Zhang, J., & Chang, L. (2021) · Frontiers in Plant Science · doi:10.3389/fpls.2021.584042 · Cited by 24
Blood Flow Patterns Spatially Associated with Platelet Aggregates in Murine Colitis
Miele, L. F., Turhan, A., Lee, G. S., Lin, M., Ravnic, D. J., Tsuda, A., Konerding, M. A., & Mentzer, S. J. (2009) · The Anatomical Record · doi:10.1002/ar.20954 · Cited by 24
Christodoulakos, G., Lambrinoudaki, I. V., Economou, E. V., Papadias, C. B., Vitoratos, N., Panoulis, C., Kouskouni, E. E., Vlachou, S. A., & Creatsas, G. C. (2006) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2006.05.045 · Cited by 24
Leukotriene pathway in sickle cell disease: a potential target for directed therapy
Knight‐Perry, J. E., DeBaun, M. R., Strunk, R. C., & Field, J. J. (2009) · Expert Review of Hematology · doi:10.1586/17474086.2.1.57 · Cited by 24
Changes in Cytokine Levels in Patients with Severe Fever with Thrombocytopenia Syndrome Virus
Xu, D., Zhang, X., Tian, X., Wang, X., Zhao, L., Gao, M., Li, L., Zhao, J.-Q., Cao, W., & Ding, S. (2024) · Journal of Inflammation Research · doi:10.2147/jir.s444398 · Cited by 23
Takeyama, H., Mizushima, T., Iijima, H., Shinzaki, S., Uemura, M., Nishimura, J., Hata, T., Takemasa, I., Yamamoto, H., Doki, Y., et al. (2015) · Digestive Diseases and Sciences · doi:10.1007/s10620-015-3745-2 · Cited by 23
Raised Soluble P-Selectin Moderately Accelerates Atherosclerotic Plaque Progression
Woollard, K. J., Lumsden, N. G., Andrews, K. L., Aprico, A., Harris, E., Irvine, J. C., Jefferis, A., Lu, F. Y., Kanellakis, P., Bobik, A., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0097422 · Cited by 23
Chemokines and chemokine receptors
Murphy, P. M. (2008) · Elsevier eBooks · doi:10.1016/b978-0-323-04404-2.10011-9 · Cited by 26
Johansson, S. E., Talloen, W., Tuefferd, M., Darling, J. M., Scholliers, A., Fanning, G., Fried, M. W., & Aerssens, J. (2015) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.13389 · Cited by 21
Doux, J. D., Bazar, K. A., Lee, P. Y., & Yun, A. J. (2005) · Medical Hypotheses · doi:10.1016/j.mehy.2004.12.021 · Cited by 21
Stimulus‐dependent release of tissue‐regenerating factors by equine platelets
Dunkel, B., Bolt, D. M., SMITH, R. K., & Cunningham, F. M. (2011) · Equine Veterinary Journal · doi:10.1111/j.2042-3306.2011.00431.x · Cited by 21
Dynamics and thermodynamic properties of CXCL7 chemokine
Herring, C. A., Singer, C. M., Ermakova, E. A., Khairutdinov, B. I., Zuev, Y. F., Jacobs, D. J., & Nesmelova, I. V. (2015) · Proteins Structure Function and Bioinformatics · doi:10.1002/prot.24913 · Cited by 20
Harless, W. W. (2009) · BMC Cancer · doi:10.1186/1471-2407-9-118 · Cited by 20
Nkambule, B. B., Davison, G. M., & Ipp, H. (2015) · Thrombosis Research · doi:10.1016/j.thromres.2015.01.031 · Cited by 19
Design and validation of a disease network of inflammatory processes in the NSG-UC mouse model
Jodeleit, H., Palamides, P., Beigel, F., Mueller, T. D., Wolf, E., Siebeck, M., & Gropp, R. (2017) · Journal of Translational Medicine · doi:10.1186/s12967-017-1368-4 · Cited by 19
Metadata
- Authors
- GEAR, A. R. L., & CAMERINI, D.
- Affiliations
- University of Virginia (US)
- Corresponding author
- GEAR, ADRIAN R.L.
- ORCID
- CAMERINI, DAVID
- Venue
- Microcirculation
- Publisher
- Wiley
- Published
- 2003-07
- Volume
- 10
- Issue
- 3-4
- Pages
- 335-350
- ISSN
- 1073-9688 (ISSN-L)
- 1549-8719
- OpenAlex
- W2001798594
- Cited by
- 317
- References
- 161
- Citations by year
- 2026: 4 · 2025: 4 · 2024: 10 · 2023: 4 · 2022: 10 · 2021: 13 · 2020: 13 · 2019: 7 · 2018: 10 · 2017: 13 · 2016: 17 · 2015: 28 · 2014: 18 · 2013: 6 · 2012: 21
- FWCI
- 2.80
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Microcirculation (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health (1r29ai039943-01a1)
- National Institute of Allergy and Infectious Diseases (AI 39943)
- National Institute of Diabetes and Digestive and Kidney Diseases (DK59004)
- Topics
- Health Sciences › Medicine › Hematology › Platelet Disorders and Treatments
- Health Sciences › Medicine › Oncology › Chemokine receptors and signaling
- Health Sciences › Medicine › Hematology › Blood Coagulation and Thrombosis Mechanisms
- Keywords
- chemokine receptors, platelet activation, platelet aggregation, hemostasis, inflammation, host defense, CXCL12, CCL17, CCL22, CXCR4, CCR4, alpha-granule proteins, atherosclerosis, leukocyte recruitment, platelet factor 4, CCL3, RANTES, CCL7, interleukin-8
- MeSH terms
- Blood Platelets, Hemostasis, Humans, Immunity, Inflammation, Chemokines, Receptors, Chemokine
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review